Furthermore, Takano and colleagues found that the PPARγ agonist pioglitazone down-regulated COX-2 and cyclin D1 and inhibited colon cancer proliferation and liver metastasis [118]. The gene discussed is PPARG; the disease is colonic neoplasm.